EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Ezetimibe and Simvastatin Reduce Cholesterol Levels in Zebrafish Larvae Fed a High-Cholesterol Diet

Ji Sun Baek, Longhou Fang, Andrew C Li, Yury I Miller

Cholesterol · 2012

DOI: 10.1155/2012/564705 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cholesterol, 2012. Verfasst von Ji Sun Baek und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of California, San Diego, La Jolla, CA 92093, USA. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: NHLBI NIH HHS, National Institutes of Health, Merck, Inc..

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cholesterol-fed zebrafish is an emerging animal model to study metabolic, oxidative, and inflammatory vascular processes relevant to pathogenesis of human atherosclerosis. Zebrafish fed a high-cholesterol diet (HCD) develop hypercholesterolemia and are characterized by profound lipoprotein oxidation and vascular lipid accumulation. Using optically translucent zebrafish larvae has the advantage of monitoring vascular pathology and assessing the efficacy of drug candidates in live animals. Thus, we investigated whether simvastatin and ezetimibe, the principal drugs used in management of hypercholesterolemia in humans, would also reduce cholesterol levels in HCD-fed zebrafish larvae. We found that ezetimibe was well tolerated by zebrafish and effectively reduced cholesterol levels in HCD-fed larvae. In contrast, simvastatin added to water was poorly tolerated by zebrafish larvae and, when added to food, had little effect on cholesterol levels in HCD-fed larvae. Combination of low doses of ezetimibe and simvastatin had an additive effect in reducing cholesterol levels in zebrafish. These results suggest that ezetimibe exerts in zebrafish a therapeutic effect similar to that in humans and that the hypercholesterolemic zebrafish can be used as a low-cost and informative model for testing new drug candidates and for investigating mechanisms of action for existing drugs targeting dyslipidemia.

Autor:innen und Institutionen

  • Department of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.

Förderung

  • NHLBI NIH HHS
  • National Institutes of Health
  • Merck, Inc.

Zitieren

APA

Baek, J. S., Fang, L., Li, A. C., & Miller, Y. I. (2012). Ezetimibe and Simvastatin Reduce Cholesterol Levels in Zebrafish Larvae Fed a High-Cholesterol Diet. Cholesterol. https://doi.org/10.1155/2012/564705

Vancouver

Baek JS, Fang L, Li AC, Miller YI. Ezetimibe and Simvastatin Reduce Cholesterol Levels in Zebrafish Larvae Fed a High-Cholesterol Diet. Cholesterol. 2012. doi:10.1155/2012/564705

BibTeX
@article{Baek2012,
  author = {Baek, Ji Sun and Fang, Longhou and Li, Andrew C and Miller, Yury I},
  title = {Ezetimibe and Simvastatin Reduce Cholesterol Levels in Zebrafish Larvae Fed a High-Cholesterol Diet},
  journal = {Cholesterol},
  year = {2012},
  doi = {10.1155/2012/564705}
}
Kostenlos starten →